LRRK2 and Parkinson disease: In addition to the variable age at onset in patients carrying the G2019S mutation, the G2019S mutation has been shown to have reduced penetrance, meaning that there are more mutation carriers, when compared to other LRRK2 mutations, who do not develop PD throughout their lives.